Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Cited by (165)

Items 101–165 of 165

1. Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2
   Youk, Jeonghwan, Kim, Taewoo, Evans, Kelly V., Jeong, Young-Il, Hur, Yongsuk, Hong, Seon Pyo, Kim, Je Hyoung, Yi, Kijong, Kim, Su Yeon, Na, Kwon Joong et al. · 2020 · Cell Stem Cell
2. Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
   Crawford, Katharine H D, Dingens, Adam S, Eguia, Rachel, Wolf, Caitlin R, Wilcox, Naomi, Logue, Jennifer K, Shuey, Kiel, Casto, Amanda M, Fiala, Brooke, Wrenn, Samuel et al. · 2021 · The Journal of Infectious Diseases
3. SARS-CoV-2 escape <i>in vitro</i> from a highly neutralizing COVID-19 convalescent plasma
   Andreano, Emanuele, Piccini, Giulia, Licastro, Danilo, Casalino, Lorenzo, Johnson, Nicole V., Paciello, Ida, Monego, Simeone Dal, Pantano, Elisa, Manganaro, Noemi, Manenti, Alessandro et al. · 2020
4. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
   Zhou, Daming, Duyvesteyn, Helen M. E., Chen, Cheng-Pin, Huang, Chung-Guei, Chen, Ting-Hua, Shih, Shin-Ru, Lin, Yi-Chun, Cheng, Chien-Yu, Cheng, Shu-Hsing, Huang, Yhu-Chering et al. · 2020 · Nature Structural &amp; Molecular Biology
5. Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
   Glasgow, Anum, Glasgow, Jeff, Limonta, Daniel, Solomon, Paige, Lui, Irene, Zhang, Yang, Nix, Matthew A., Rettko, Nicholas J., Zha, Shoshana, Yamin, Rachel et al. · 2020 · Proceedings of the National Academy of Sciences
6. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity
   Ovsyannikova, Inna G., Haralambieva, Iana H., Crooke, Stephen N., Poland, Gregory A., Kennedy, Richard B. · 2020 · Immunological Reviews
7. A human coronavirus evolves antigenically to escape antibody immunity
   Eguia, Rachel, Crawford, Katharine H. D., Stevens-Ayers, Terry, Kelnhofer-Millevolte, Laurel, Greninger, Alexander L., Englund, Janet A., Boeckh, Michael J., Bloom, Jesse D. · 2020
8. Early postmortem brain MRI findings in COVID-19 non-survivors
   Coolen, Tim, Lolli, Valentina, Sadeghi, Niloufar, Rovaï, Antonin, Trotta, Nicola, Taccone, Fabio Silvio, Creteur, Jacques, Henrard, Sophie, Goffard, Jean-Christophe, De Witte, Olivier et al. · 2020
9. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population
   Torres Acosta, Manuel A., Singer, Benjamin D. · 2020 · European Respiratory Journal
10. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
    Edara, Venkata Viswanadh, Norwood, Carson, Floyd, Katharine, Lai, Lilin, Davis-Gardner, Meredith E., Hudson, William H., Mantus, Grace, Nyhoff, Lindsay E., Adelman, Max W., Fineman, Rebecca et al. · 2021 · Cell Host &amp; Microbe
11. SARS-CoV-2 spreads through cell-to-cell transmission
    Zeng, Cong, Evans, John P., King, Tiffany, Zheng, Yi-Min, Oltz, Eugene M., Whelan, Sean P. J., Saif, Linda J., Peeples, Mark E., Liu, Shan-Lu · 2022 · Proceedings of the National Academy of Sciences
12. An <i>Alphavirus</i> -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
    Erasmus, Jesse H., Khandhar, Amit P., O’Connor, Megan A., Walls, Alexandra C., Hemann, Emily A., Murapa, Patience, Archer, Jacob, Leventhal, Shanna, Fuller, James T., Lewis, Thomas B. et al. · 2020 · Science Translational Medicine
13. An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells
    Lamers, Mart M, van der Vaart, Jelte, Knoops, Kèvin, Riesebosch, Samra, Breugem, Tim I, Mykytyn, Anna Z, Beumer, Joep, Schipper, Debby, Bezstarosti, Karel, Koopman, Charlotte D et al. · 2021 · The EMBO Journal
14. Immunological imprinting of the antibody response in COVID-19 patients
    Aydillo, Teresa, Rombauts, Alexander, Stadlbauer, Daniel, Aslam, Sadaf, Abelenda-Alonso, Gabriela, Escalera, Alba, Amanat, Fatima, Jiang, Kaijun, Krammer, Florian, Carratala, Jordi et al. · 2021 · Nature Communications
15. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
    Wang, Rui, Chen, Jiahui, Gao, Kaifu, Wei, Guo-Wei · 2021 · Genomics
16. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
    Greaney, Allison J., Loes, Andrea N., Crawford, Katharine H.D., Starr, Tyler N., Malone, Keara D., Chu, Helen Y., Bloom, Jesse D. · 2021
17. The SARS-CoV-2 Spike variant D614G favors an open conformational state
    Mansbach, Rachael A., Chakraborty, Srirupa, Nguyen, Kien, Montefiori, David C., Korber, Bette, Gnanakaran, S. · 2021 · Science Advances
18. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
    Walls, Alexandra C., Miranda, Marcos C., Schäfer, Alexandra, Pham, Minh N., Greaney, Allison, Arunachalam, Prabhu S., Navarro, Mary-Jane, Tortorici, M. Alejandra, Rogers, Kenneth, O’Connor, Megan A. et al. · 2021 · Cell
19. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
    Vanshylla, Kanika, Di Cristanziano, Veronica, Kleipass, Franziska, Dewald, Felix, Schommers, Philipp, Gieselmann, Lutz, Gruell, Henning, Schlotz, Maike, Ercanoglu, Meryem S., Stumpf, Ricarda et al. · 2021 · Cell Host &amp; Microbe
20. SARS-CoV-2 infection, COVID-19 pathogenesis, and exposure to air pollution: What is the connection?
    Woodby, Brittany, Arnold, Michelle M., Valacchi, Giuseppe · 2021 · Annals of the New York Academy of Sciences
21. Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
    Singh, Satarudra Prakash, Pritam, Manisha, Pandey, Brijesh, Yadav, Thakur Prasad · 2021 · Journal of Medical Virology
22. mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
    Rauch, Susanne, Roth, Nicole, Schwendt, Kim, Fotin-Mleczek, Mariola, Mueller, Stefan O., Petsch, Benjamin · 2021 · npj Vaccines
23. Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
    Shan, Sisi, Luo, Shitong, Yang, Ziqing, Hong, Junxian, Su, Yufeng, Ding, Fan, Fu, Lili, Li, Chenyu, Chen, Peng, Ma, Jianzhu et al. · 2022 · Proceedings of the National Academy of Sciences
24. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
    Chan, Kui K., Tan, Timothy J. C., Narayanan, Krishna K., Procko, Erik · 2021 · Science Advances
25. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
    Cele, Sandile, Gazy, Inbal, Jackson, Laurelle, Hwa, Shi-Hsia, Tegally, Houriiyah, Lustig, Gila, Giandhari, Jennifer, Pillay, Sureshnee, Wilkinson, Eduan, Naidoo, Yeshnee et al. · 2021
26. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
    Ribeiro, Deidiane Elisa, Oliveira-Giacomelli, Ágatha, Glaser, Talita, Arnaud-Sampaio, Vanessa F., Andrejew, Roberta, Dieckmann, Luiz, Baranova, Juliana, Lameu, Claudiana, Ratajczak, Mariusz Z., Ulrich, Henning · 2021 · Molecular Psychiatry
27. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
    McCallum, Matthew, Marco, Anna De, Lempp, Florian, Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex, Liu, Zhuoming, Zatta, Fabrizia et al. · 2021
28. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients
    Klimstra, William B., Tilston-Lunel, Natasha L., Nambulli, Sham, Boslett, James, McMillen, Cynthia M., Gilliland, Theron, Dunn, Matthew D., Sun, Chengun, Wheeler, Sarah E., Wells, Alan et al. · 2020 · Journal of General Virology
29. A Comprehensive Review About SARS-CoV-2
    Haque, SK Manirul, Ashwaq, Omar, Sarief, Abdulla, Azad John Mohamed, Abdul Kalam · 2020 · Future Virology
30. Approaches and Challenges in SARS-CoV-2 Vaccine Development
    Dagotto, Gabriel, Yu, Jingyou, Barouch, Dan H. · 2020 · Cell Host &amp; Microbe
31. SARS-CoV-2 RBD <i>in vitro</i> evolution follows contagious mutation spread, yet generates an able infection inhibitor
    Zahradník, Jiří, Marciano, Shir, Shemesh, Maya, Zoler, Eyal, Chiaravalli, Jeanne, Meyer, Björn, Rudich, Yinon, Dym, Orly, Elad, Nadav, Schreiber, Gideon · 2021
32. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection
    Alquisiras-Burgos, Iván, Peralta-Arrieta, Irlanda, Alonso-Palomares, Luis Antonio, Zacapala-Gómez, Ana Elvira, Salmerón-Bárcenas, Eric Genaro, Aguilera, Penélope · 2021 · Molecular Neurobiology
33. Recombinant vaccines for COVID-19
    Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K · 2020 · Human Vaccines &amp; Immunotherapeutics
34. Rapid development and deployment of high‐volume vaccines for pandemic response
    Kis, Zoltán, Kontoravdi, Cleo, Dey, Antu K., Shattock, Robin, Shah, Nilay · 2020 · Journal of Advanced Manufacturing and Processing
35. A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
    Stamatatos, Leonidas, Czartoski, Julie, Wan, Yu-Hsin, Homad, Leah J., Rubin, Vanessa, Glantz, Hayley, Neradilek, Moni, Seydoux, Emilie, Jennewein, Madeleine F., MacCamy, Anna J. et al. · 2021
36. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
    Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Zhang, Jinrong, Zhang, Donghui, Beauvais, Adrien, Anosova, Natalie G., Tibbitts, Tim, DiNapoli, Josh, Ulinski, Gregory et al. · 2021 · npj Vaccines
37. SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
    Fenrich, Matija, Mrdenovic, Stefan, Balog, Marta, Tomic, Svetlana, Zjalic, Milorad, Roncevic, Alen, Mandic, Dario, Debeljak, Zeljko, Heffer, Marija · 2020 · Frontiers in Cellular Neuroscience
38. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19
    Shah, Harsh, Khan, Md Shahjalal Hossain, Dhurandhar, Nikhil V., Hegde, Vijay · 2021 · Acta Diabetologica
39. Tackling COVID-19 with neutralizing monoclonal antibodies
    Corti, Davide, Purcell, Lisa A., Snell, Gyorgy, Veesler, David · 2021 · Cell
40. C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System
    Pentón-Rol, Giselle, Marín-Prida, Javier, McCarty, Mark F. · 2021 · Current Neuropharmacology
41. Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro
    Yang, Ren, Huang, Baoying, A, Ruhan, Li, Wenhui, Wang, Wenling, Deng, Yao, Tan, Wenjie · 2020 · Biosafety and Health
42. Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
    Zang, Jinkai, Gu, Chenjian, Zhou, Bingjie, Zhang, Chao, Yang, Yong, Xu, Shiqi, Bai, Lulu, Zhang, Rong, Deng, Qiang, Yuan, Zhenghong et al. · 2020 · Cell Discovery
43. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
    Park, Young-Jun, Pinto, Dora, Walls, Alexandra C., Liu, Zhuoming, De Marco, Anna, Benigni, Fabio, Zatta, Fabrizia, Silacci-Fregni, Chiara, Bassi, Jessica, Sprouse, Kaitlin R. et al. · 2022
44. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
    Hosoki, Koa, Chakraborty, Abhijit, Sur, Sanjiv · 2020 · Journal of Allergy and Clinical Immunology
45. Exploring the Role of Endothelial Cell Resilience in Cardiovascular Health and Disease
    Gao, Yunling, Galis, Zorina S. · 2021 · Arteriosclerosis, Thrombosis, and Vascular Biology
46. Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
    Liu, Jun, Budylowski, Patrick, Samson, Reuben, Griffin, Bryan D., Babuadze, Giorgi, Rathod, Bhavisha, Colwill, Karen, Abioye, Jumai A., Schwartz, Jordan A., Law, Ryan et al. · 2022 · Science Advances
47. Repurposing potential of FDA‐approved and investigational drugs for COVID‐19 targeting SARS‐CoV‐2 spike and main protease and validation by machine learning algorithm
    Verma, Akalesh Kumar, Aggarwal, Rohit · 2021 · Chemical Biology &amp; Drug Design
48. A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation
    Kimura, Taishi, Leal, Joseph M., Simpson, Adrian, Warner, Nikole L., Berube, Bryan J., Archer, Jacob F., Park, Stephanie, Kurtz, Ryan, Hinkley, Troy, Nicholes, Katrina et al. · 2023 · Molecular Therapy
49. COVID-19 as a trigger for type 1 diabetes
    Wang, Yichen, Guo, Hui, Wang, Gongquan, Zhai, Jiawei, Du, Bing · 2023 · The Journal of Clinical Endocrinology &amp; Metabolism
50. COVID-19 and the digestive system: A comprehensive review
    Wang, Ming-Ke, Yue, Hai-Yan, Cai, Jin, Zhai, Yu-Jia, Peng, Jian-Hui, Hui, Ju-Fen, Hou, Deng-Yong, Li, Wei-Peng, Yang, Ji-Shun · 2021 · World Journal of Clinical Cases
51. Pharmacological features, health benefits and clinical implications of honokiol
    Khatoon, Fatima, Ali, Sabeeha, Kumar, Vijay, Elasbali, Abdelbaset Mohamed, Alhassan, Hassan H., Alharethi, Salem Hussain, Islam, Asimul, Hassan, Md. Imtaiyaz · 2023 · Journal of Biomolecular Structure and Dynamics
52. DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging
    Sepe, Sara, Rossiello, Francesca, Cancila, Valeria, Iannelli, Fabio, Matti, Valentina, Cicio, Giada, Cabrini, Matteo, Marinelli, Eugenia, Alabi, Busola R, di Lillo, Alessia et al. · 2022 · The EMBO Reports
53. Anchor-Locker Binding Mechanism of the Coronavirus Spike Protein to Human ACE2: Insights from Computational Analysis
    Cong, Yalong, Feng, Yinghui, Ni, Hui, Zhi, Fengdong, Miao, Yulu, Fang, Bohuan, Zhang, Lujia, Zhang, John Z. H. · 2021 · Journal of Chemical Information and Modeling
54. Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
    Muecksch, Frauke, Weisblum, Yiska, Barnes, Christopher O., Schmidt, Fabian, Schaefer-Babajew, Dennis, Lorenzi, Julio C C, Flyak, Andrew I, DeLaitsch, Andrew T, Huey-Tubman, Kathryn E, Hou, Shurong et al. · 2021
55. Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
    Kruglova, Natalia, Siniavin, Andrei, Gushchin, Vladimir, Mazurov, Dmitriy · 2021 · Viruses
56. The receptor binding domain of SARS-CoV-2 spike is the key target of neutralizing antibody in human polyclonal sera
    Steffen, Tara L., Stone, E. Taylor, Hassert, Mariah, Geerling, Elizabeth, Grimberg, Brian T., Espino, Ana M., Pantoja, Petraleigh, Climent, Consuelo, Hoft, Daniel F., George, Sarah L. et al. · 2020
57. Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
    Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda · 2021 · Vaccines
58. Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
    Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose et al. · 2021
59. Association of COVID-19 transmission with high levels of ambient pollutants: Initiation and impact of the inflammatory response on cardiopulmonary disease
    Lai, Angela, Chang, Megan L., O'Donnell, Ryan P., Zhou, Changcheng, Sumner, Jennifer A., Hsiai, Tzung K. · 2021 · Science of The Total Environment
60. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
    Devaux, Christian A., Camoin-Jau, Laurence · 2022 · Frontiers in Microbiology
61. Counter-regulatory renin-angiotensin system in hypertension: review and update in the era of COVID-19 pandemic
    Chen, Hongyin, Peng, Jiangyun, Wang, Tengyao, Wen, Jielu, Chen, Sifan, Huang, Yu, Zhang, Yang · 2023 · Biochemical Pharmacology
62. Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
    Wang, Chunyan, van Haperen, Rien, Gutiérrez-Álvarez, Javier, Li, Wentao, Okba, Nisreen M.A., Albulescu, Irina, Widjaja, Ivy, van Dieren, Brenda, Fernandez-Delgado, Raul, Sola, Isabel et al. · 2020
63. Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
    Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Zhang, Jinrong, Zhang, Donghui, Beauvais, Adrien, Anosova, Natalie G., Tibbitts, Timothy, DiNapoli, Joshua M., Huang, Po-Wei D. et al. · 2020
64. A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy
    Devarasetti, Phani Kumar, Rajasekhar, Liza, Baisya, Ritasman, Sreejitha, K. S., Vardhan, Yerram Keerthi · 2021 · Immunologic Research
65. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
    Piccoli, Luca, Park, Young-Jun, Tortorici, M. Alejandra, Czudnochowski, Nadine, Walls, Alexandra C., Beltramello, Martina, Silacci-Fregni, Chiara, Pinto, Dora, Rosen, Laura E., Bowen, John E. et al. · 2020 · Cell